Chromatin-remodeling protein BRG1/SMARCA4 is pivotal for establishing oligodendrocyte (OL) lineage identity. However, its functions for oligodendrocyte-precursor cell (OPC) differentiation within the postnatal brain and during remyelination remain elusive. Here, we demonstrate that Brg1 loss profoundly impairs OPC differentiation in the brain with a comparatively lesser effect in the spinal cord. Moreover, BRG1 is critical for OPC remyelination after injury. Integrative transcriptomic/genomic profiling reveals that BRG1 exhibits a dual role by promoting OPC differentiation networks while repressing OL-inhibitory cues and proneuronal programs. Furthermore, we find that BRG1 interacts with EED/PRC2 polycomb-repressive-complexes to enhance H3K27me3-mediated repression at gene loci associated with OL-differentiation inhibition and neurogenesis. Notably, BRG1 depletion decreases H3K27me3 deposition, leading to the upregulation of BMP/WNT signaling and proneurogenic genes, which suppresses OL programs. Thus, our findings reveal a hitherto unexplored spatiotemporal-specific role of BRG1 for OPC differentiation in the developing CNS and underscore a new insight into BRG1/PRC2-mediated epigenetic regulation that promotes and safeguards OL lineage commitment and differentiation.
Skip Nav Destination
Article navigation
1 July 2024
Article|
April 23 2024
BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination
In Special Collection:
Cellular Neurobiology 2024
Jiajia Wang
,
Jiajia Wang
(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing - original draft, Writing - review & editing)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Search for other works by this author on:
Lijun Yang
,
Lijun Yang
(Data curation, Formal analysis)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Search for other works by this author on:
Yiwen Du
,
Yiwen Du
(Investigation, Methodology)
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Search for other works by this author on:
Jincheng Wang
,
Jincheng Wang
(Data curation, Investigation, Methodology)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Search for other works by this author on:
Qinjie Weng
,
Qinjie Weng
(Resources)
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Search for other works by this author on:
Xuezhao Liu
,
Xuezhao Liu
(Investigation)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Search for other works by this author on:
Eva Nicholson
,
Eva Nicholson
(Writing - review & editing)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Search for other works by this author on:
Mei Xin,
Mei Xin
(Writing - review & editing)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Search for other works by this author on:
Qing Richard Lu
(Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing)
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
3Division of Developmental Biology, Department of Pediatrics,
University of Cincinnati School of Medicine
, Cincinnati, OH, USA
Correspondence to Qing Richard Lu: [email protected]
Search for other works by this author on:
Jiajia Wang
Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing - original draft, Writing - review & editing
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Lijun Yang
Data curation, Formal analysis
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Yiwen Du
Investigation, Methodology
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Jincheng Wang
Data curation, Investigation, Methodology
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Qinjie Weng
Resources
2Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences,
Zhejiang University
, Hangzhou, China
Xuezhao Liu
Investigation
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Eva Nicholson
Writing - review & editing
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Mei Xin
Writing - review & editing
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
Qing Richard Lu
Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing
1Division of Experimental Hematology and Cancer Biology,
Cincinnati Children’s Hospital Medical Center
, Cincinnati, OH, USA
3Division of Developmental Biology, Department of Pediatrics,
University of Cincinnati School of Medicine
, Cincinnati, OH, USA
Correspondence to Qing Richard Lu: [email protected]
Disclosures: The authors declare no competing interests exist.
Received:
October 30 2023
Revision Received:
March 01 2024
Accepted:
March 28 2024
Online ISSN: 1540-8140
Print ISSN: 0021-9525
Funder(s):
National Natural Science Foundation of China
- Award Id(s): No. 82104181
Funder(s):
National Multiple Sclerosis Society
- Award Id(s): RG2110
© 2024 Wang et al.
2024
Wang et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2024) 223 (7): e202310143.
Article history
Received:
October 30 2023
Revision Received:
March 01 2024
Accepted:
March 28 2024
Citation
Jiajia Wang, Lijun Yang, Yiwen Du, Jincheng Wang, Qinjie Weng, Xuezhao Liu, Eva Nicholson, Mei Xin, Qing Richard Lu; BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. J Cell Biol 1 July 2024; 223 (7): e202310143. doi: https://doi.org/10.1083/jcb.202310143
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement